高血压杂志
高血壓雜誌
고혈압잡지
2001年
2期
108-109
,共2页
韩阳%蒋伟莉%金美珍%葛炜%陈天秩
韓暘%蔣偉莉%金美珍%葛煒%陳天秩
한양%장위리%금미진%갈위%진천질
直立倾斜试验%血管迷走性晕厥%一平苏
直立傾斜試驗%血管迷走性暈厥%一平囌
직립경사시험%혈관미주성훈궐%일평소
目的 观察一平苏对血管迷走性晕厥的疗效。方法 对86例倾斜试验阳性晕厥患者给予一平苏 2.5 mg/d，3月后复查倾斜试验并随访。结果 除7例有咳嗷或其他原因退出试验外，余79例倾斜试验阴转率为75.95%。服药期间无一例发生晕厥。治疗前卧位血压为121/73 mmHg,治疗后为 120/76 mmHg,P>0.05。心率在治疗前后分别为68±13 和 70±13/min，两者无显著性差异。结论 一平苏可以作为治疗血管迷走性晕厥的有效药物，副作用少，对正常血压和心率无影响。
目的 觀察一平囌對血管迷走性暈厥的療效。方法 對86例傾斜試驗暘性暈厥患者給予一平囌 2.5 mg/d，3月後複查傾斜試驗併隨訪。結果 除7例有咳嗷或其他原因退齣試驗外，餘79例傾斜試驗陰轉率為75.95%。服藥期間無一例髮生暈厥。治療前臥位血壓為121/73 mmHg,治療後為 120/76 mmHg,P>0.05。心率在治療前後分彆為68±13 和 70±13/min，兩者無顯著性差異。結論 一平囌可以作為治療血管迷走性暈厥的有效藥物，副作用少，對正常血壓和心率無影響。
목적 관찰일평소대혈관미주성훈궐적료효。방법 대86례경사시험양성훈궐환자급여일평소 2.5 mg/d，3월후복사경사시험병수방。결과 제7례유해오혹기타원인퇴출시험외，여79례경사시험음전솔위75.95%。복약기간무일례발생훈궐。치료전와위혈압위121/73 mmHg,치료후위 120/76 mmHg,P>0.05。심솔재치료전후분별위68±13 화 70±13/min，량자무현저성차이。결론 일평소가이작위치료혈관미주성훈궐적유효약물，부작용소，대정상혈압화심솔무영향。
Objective To evaluate cilazapil in the treatment of vasovagal syncope. Methods Eighty six vasovagal syncope patients(positive in TTT test) recieved cilazapril 2.5 mg daily for three months and retested by TTT test. Results Seven cases quitted for cough and other sake. Syncope was vanished in 79 patients(100%) in the treatment period and 75.9% of TTT positive test changeed to negative after 3 months medication. The blood pressure in lying position were no different before and after treatment(121/73 mmHg vs 120/76 mmHg,P>0.05). The mean heart rates were of no changes either 68±13 and 70±13/min. Conclusion Cilazapril was effective in treatment of VVS. It didn't affect normal blood pressure and heart rates. The treatment was safe and no side effects were found.
